Trial ID | Random sequence generation | Allocation concealment | Blinding | Incomplete outcome data | Selective outcome reporting | Other sources of bias |
---|---|---|---|---|---|---|
Uwe Reuter 2018 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
David W Dodick 2017 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Peter J. Goadsby 2017 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Hong Sun 2016 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
David W Dodick 2014 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
David W. Dodick 2018 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Marcelo E Bigal 2015 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Vladimir Skljarevski 2018 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Vladimir Skljarevski 2017 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Virginia L. Stauffer 2018 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
David W Dodick 2014 | Low risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |